France / Français
A biotech that's developing a drug for a rare metabolic disorder is exploring going public in 2019
7 monthes ago - By Business Insider
New York-based biotech Applied Therapeutics is exploring an initial public offering in the first half of 2019, according to people familiar with the matter.
The company's developing a drug for a rare metabolic disorder, as well as treatments for diabetes complications.
The red hot market for biotech IPOs may have another entrant.
New York-based Applied Therapeutics, which is developing treatments for cardio-metabolic conditions, is exploring an IPO that could land in first half of next year, according to people familiar with the matter.
The people cautioned that timing could change...
Read more ...
Search by Tags
Marketing Fund Investments New York Invest Market Companies Investment Company Land Management
The headlines of Business Mag
HOLD FAMILY A multiplayer network game for families
Spend more time with your family and less with your phone with the Hold Family app made by us! :)
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
5 Exciting Account-Based Marketing Examples
How many retargeting ads do you encounter in a day? What about semi-personalized emails in your inbox? Probably too many to count. Now, how many times is your team offered a...
Russia says too early to discuss OPEC+ deal extension
OPEC countries and allied producers need to discuss the situation on the market before making proposals for the cartel's meeting in June, Russia's energy minister has said amid...
This VC fund is betting $105 million on Texas tech startups as more talent...
LiveOak Venture Partners thinks there's a goldmine in the Texas tech scene. The investment firm has focused on Lone Star State startups and plans to use its new $105 million...
One market expert warns these 3 'black swan' events could combine with the...
President Donald Trump's ongoing trade war with China has reintroduced volatility to the stock market. Some experts say this leaves equities particularly exposed to an external...
Conversion Conclusion
There are so many varieties of lead-generation sources that it's almost overwhelming to agents and the brokers trying to provide the best leads to their agents and teams. While...
Uber's historic loss, Lyft's abysmal month, Pinterest's earnings disaster...
The US initial-public-offering market has been packed with high-profile debuts of all sizes this year. But some of the most widely anticipated launches have faltered in their...
We drove a $38,000 Subaru Crosstrek Hybrid to see if it's worth the money...
The Subaru Crosstrek is one of the more popular compact crossovers on the market today. Based on the compact Impreza hatchback, the Crosstrek is a tweener that straddles the...
A VC with $575 million to spend lists the 3 qualities startups need to get...
Accel is a major venture company that has backed famous firms including Facebook, Spotify, and Slack. Its European arm has raised a new $575 million fund for entrepreneurs on...
The history of how Uber went from the most feared startup in the world to...
Carlo Allegri/Reuters Uber went public this month on the New York Stock Exchange in a much-watched IPO. Since it was founded in 2009, Uber has transformed the ride-hailing...
2019 Engagement Benchmarks for Apps in the Shopping Category
All apps aren't created equal, and metrics of success look different across industries based on differences in customer engagement opportunities and goals. In order to fully...